Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors.
Byun JM, Koh Y, Shin DY, Kim I, Yoon SS, Lee JO, Bang SM, Kim KH, Jung SH, Lee WS, Park Y, Jang JH, Han JJ, Yhim HY, Kim DS, Lee YJ, Lee H, Choi YS, Lee S; Korean Adult ALL Working Party, Korean Society of Hematology. Byun JM, et al. Among authors: kim ds, kim i, kim kh. Haematologica. 2017 May;102(5):e187-e190. doi: 10.3324/haematol.2016.159988. Epub 2017 Jan 12. Haematologica. 2017. PMID: 28082339 Free PMC article. No abstract available.
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY. Yhim HY, et al. Among authors: kim ds, kim s, kim sj, kim ws, kim k, kim mk. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2274-2284. doi: 10.1007/s00259-018-4093-1. Epub 2018 Jul 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 30056546
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY. Yhim HY, et al. Among authors: kim ds, kim s, kim sj, kim ws, kim k, kim mk. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2482-2483. doi: 10.1007/s00259-018-4163-4. Eur J Nucl Med Mol Imaging. 2018. PMID: 30221329
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party.
Jung SH, Lee SR, Yang DH, Lee S, Yoon JH, Lee H, Bang SM, Koh Y, Park S, Kim DS, Yhim HY, Kim SH, Lee JH, Sohn SK, Song IC, Lee HG, Cheong JW, Choi Y, Shin HJ. Jung SH, et al. Among authors: kim ds, kim sh. Ann Hematol. 2019 Jan;98(1):151-158. doi: 10.1007/s00277-018-3495-2. Epub 2018 Sep 26. Ann Hematol. 2019. PMID: 30259121 Clinical Trial.
Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia.
Lee SS, Jung SH, Do YR, Kim DS, Lee JH, Park HS, Moon JH, Yi JH, Park Y, Koh Y, Yhim HY, Choi Y, Mun YC, Lee WS, Lee S, Yang DH; Korean Adult Acute Lymphoblastic Leukemia Working Party. Lee SS, et al. Among authors: kim ds. Yonsei Med J. 2020 Jun;61(6):452-459. doi: 10.3349/ymj.2020.61.6.452. Yonsei Med J. 2020. PMID: 32469169 Free PMC article.
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
Lee JH, Park Y, Kang KW, Lee JJ, Lee HS, Eom HS, Do YR, Kim JS, Yoon SS, Shin DY, Koh Y, Kim KH, Lee WS, Jo JC, Lee YJ, Lee JY, Kim DS, Shim H, Chang MH, Kim SH, Min CK; Korean multiple myeloma working party [KMMWP]. Lee JH, et al. Among authors: kim ds, kim sh, kim js, kim kh. Ann Hematol. 2021 Aug;100(8):2051-2059. doi: 10.1007/s00277-021-04407-0. Epub 2021 Jan 15. Ann Hematol. 2021. PMID: 33447888
Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.
Yi JH, Kim SJ, Yoon DH, Suh C, Chang MH, Yang DH, Jo JC, Hyun SY, Eom HS, Lee JO, Kwon JH, Han SH, Lee SS, Kwak JY, Kim SH, Kim DS, Lee JH, Oh SY, Ryoo HM, Kim HJ, Kim WS. Yi JH, et al. Among authors: kim ds, kim hj, kim sh, kim sj, kim ws. Cancer Commun (Lond). 2021 Mar;41(3):275-278. doi: 10.1002/cac2.12150. Epub 2021 Feb 24. Cancer Commun (Lond). 2021. PMID: 33626235 Free PMC article. No abstract available.
4,615 results